Viruses

Increased blood clotting during hospital stay is linked to lung function problems after discharge in COVID-19 pneumonia patients

Updated

Abstract

Essence

Hypercoagulable profiles during COVID-19 pneumonia hospitalization were linked to later symptoms and impaired lung diffusion after discharge.

Evidence

This prospective observational study followed 62 hospitalized patients with serial ROTEM testing and found hypercoagulable indices at enrollment, discharge, and 1 month post-discharge were associated with persistent symptoms and impairment by 3 months.

Caveat

Because this was an observational study in a small COVID-19 pneumonia cohort, the findings cannot show that excessive coagulation causes long-COVID sequelae.

Simplified

Key numbers

16 of 44 patients
Increased Risk of Symptoms
Patients experiencing symptoms at one month after discharge.
3 months post-discharge
Abnormal Association
Patients with impaired (<80% of predicted value).
9 of 10 patients
Hypercoagulable Profiles
Patients with hypercoagulable at clinical deterioration.

Full Text

What this is

  • This study investigates the relationship between hypercoagulable rotational thromboelastometry () profiles and clinical outcomes in patients hospitalized with COVID-19 pneumonia.
  • It explores whether can predict post-discharge symptoms and lung diffusion capacity impairment.
  • The research includes 62 patients and examines at key clinical time points during hospitalization and follow-up.

Essence

  • Hypercoagulable profiles during hospitalization are linked to persistent symptoms and impaired lung function in COVID-19 pneumonia patients after discharge.

Key takeaways

  • A hypercoagulable profile was more common during clinical deterioration than at enrollment, indicating a worsening coagulation status.
  • Patients with hypercoagulable at discharge and one month post-discharge had a higher risk of persistent symptoms at one and three months after discharge.
  • Hypercoagulable at enrollment, discharge, and one month post-discharge was associated with abnormal lung diffusion capacity () three months after discharge.

Caveats

  • The study is limited by its small sample size and single-center design, which restricts the generalizability of the findings.
  • The absence of a non-COVID-19 control group limits comparisons regarding long-term symptoms in other pneumonia cases.
  • Some patients did not attend follow-up visits, which may affect the assessment of post-discharge outcomes.

Definitions

  • hypercoagulability: An increased tendency of blood to form clots, which can lead to thrombosis and related complications.
  • ROTEM: Rotational thromboelastometry, a test that evaluates the dynamics of blood coagulation and clot formation.
  • DLco: Diffusing capacity of the lungs for carbon monoxide, a measure of lung function and gas exchange efficiency.

Simplified

Funding

Competing interests

0 of 11
authors report competing interests
11 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free